| Patient | Howard Hughes |
|---|---|
| Date of birth | 1905-12-24 |
| Identifiers | MRN HR-ML006-SYN-TD; SSN (made up) 000-06-5571 |
| Document date | 2026-11-01 |
| Author | Anselm Garrity-Moyo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing primary care ten months after a plane crash: contamination fears with washing and avoidance, chronic pain on long-term codeine, an opioid review, hearing, weight, kidney health and safety. Concerns: He wants to get back to full days of work without hours of washing and checking, and without other people seeing his rituals; He is afraid that without codeine the pain from the crash will stop him working; He wants his privacy protected and nothing about his care known outside the clinic. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 300 mg with codeine 30 mg oral tablet, prescribed elsewhere since the crash as one or two tablets every 6 hours as needed, no more than 8 a day; he has been taking 10 to 12 a day | One or two tablets every 6 hours as needed, no more than 8 a day | Oral route | 1947-05-04 to 1947-05-11 | completed | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with instruction for him and his household staff | One spray as needed for suspected overdose; repeat in 2 to 3 minutes if needed | Nasal route | 1947-05-04 | active | S |
| Buprenorphine 2 mg with naloxone 0.5 mg sublingual film for the first day: 4 mg once withdrawal is moderate (COWS 12 or more), then 2 to 4 mg every one to two hours as needed, to no more than 16 mg on the first day | First-day induction by the written plan, no more than 16 mg | Sublingual route | 1947-05-11 to 1947-05-12 | completed | S |
| Buprenorphine 8 mg with naloxone 2 mg sublingual film, one film twice daily (16 mg a day), for opioid use disorder and pain; dispensed one week at a time at first | One film under the tongue twice daily | Sublingual route | 1947-05-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain after the crash, now that codeine combination tablets have stopped | Two tablets three times daily, no more than 3,000 mg a day | Oral route | 1947-05-11 | active | S |
| Sertraline 50 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1947-05-11 to 1947-06-08 | completed | S |
| Sertraline 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1947-06-08 to 1947-07-13 | completed | S |
| Sertraline 100 mg oral tablet, two tablets daily (200 mg), the usual target range for OCD | Two tablets daily | Oral route | 1947-07-13 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Pure-tone audiometry: bilateral high-frequency sensorineural hearing loss with a notch at 4000 Hz; speech discrimination good in quiet | 1947-06-08 to 1947-06-08 | completed | S |
| Hearing aid fitting: bilateral behind-the-ear hearing aids with a remote microphone for meetings | 1947-07-13 to 1947-07-13 | completed | S |
| Advance care planning conversation, about 16 minutes | 1947-09-14 to 1947-09-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1947-09-14 | Influenza vaccine for the coming season | completed | S |
| 1947-09-14 | Tdap vaccine; no tetanus booster recorded since the crash | completed | S |
| 1947-09-14 | Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intake | completed | S |
| 1947-10-05 | COVID-19 vaccine for the coming season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1919 | Paralysis as a boy for which no cause was found, after which he developed a lasting fear for his health | D (CLM-0003) |
| 1944 | A nervous breakdown, recorded without detail | D (CLM-0004) |
| July 7, 1946 | Critical injuries in a plane crash: crushed chest, collapsed lung, multiple fractures and burns; pain and codeine since | D (CLM-0005, CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He wants to get back to full days of work without hours of washing and checking, and without other people seeing his rituals | active | S |
| He is afraid that without codeine the pain from the crash will stop him working | active | S |
| He wants his privacy protected and nothing about his care known outside the clinic | active | S |
Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.4 on 1947-05-04; Hemoglobin [Mass/volume] in Blood 14.1 on 1947-05-04; MCV [Entitic mean volume] in Red Blood Cells by Automated count 91 on 1947-05-04; Platelets [#/volume] in Blood by Automated count 248 on 1947-05-04; Sodium [Moles/volume] in Serum or Plasma 140 on 1947-10-05; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1947-10-05; Creatinine [Mass/volume] in Serum or Plasma 0.96 on 1947-10-05; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1942)/1.73 sq M 102 on 1947-10-05; Glucose [Mass/volume] in Serum or Plasma 86 on 1947-10-05; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 1947-10-05; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 on 1947-10-05; Albumin [Mass/volume] in Serum or Plasma 4.2 on 1947-10-05; Thyrotropin [Units/volume] in Serum or Plasma 1.6 on 1947-05-04; Albumin/Creatinine [Mass Ratio] in Urine 8 on 1947-05-04; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1947-10-05; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 on 1947-10-05; Total score [DAST-10] 5 on 1947-05-04; Total score [AUDIT-C] 1 on 1947-05-04; Mean score [PEG] 4 on 1947-10-05; PTSD PCL-5 score [PCL-5] 18 on 1947-05-11; Hearing threshold Ear - right --500 Hz 20 on 1947-06-08; Hearing threshold Ear - left --500 Hz 20 on 1947-06-08; Hearing threshold Ear - right --1000 Hz 25 on 1947-06-08; Hearing threshold Ear - left --1000 Hz 30 on 1947-06-08; Hearing threshold Ear - right --1921 Hz 35 on 1947-06-08; Hearing threshold Ear - left --1921 Hz 40 on 1947-06-08; Hearing threshold Ear - right --4000 Hz 60 on 1947-06-08; Hearing threshold Ear - left --4000 Hz 65 on 1947-06-08; Cholesterol [Mass/volume] in Serum or Plasma 182 on 1947-09-14; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 1947-09-14; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 1947-09-14; Triglyceride [Mass/volume] in Serum or Plasma 90 on 1947-09-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1947-09-14 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Intrusive fears of contamination by germs for about a year, worse since the crash, with hand washing, cleaning of objects and avoidance of handshakes, shared spaces and food handled by others, taking about four hours a day; he recognizes the fears are probably excessive; cause under evaluation | resolved | confirmed | R46.81 | S — Synthetic presenting problem anchored to his documented fear of germs; resolved into the diagnosis of OCD at the consultation. Not a claim about his real symptoms in 1947. |
| Obsessive-compulsive disorder, contamination type, with good or fair insight, not tic-related; Y-BOCS 28 (severe) at intake; no post-traumatic stress disorder on screening | active | confirmed | F42.2 | S — Synthetic modern diagnosis made at the consultation, linked to the retrospective interpretation of his documented fears (R). Not a claim about his real diagnosis. |
| Opioid use disorder, moderate (four of the DSM-5-TR criteria that count for a prescribed opioid: taking more than prescribed, failed attempts to cut down, time spent getting prescriptions from two prescribers, and craving), on codeine prescribed after a crash; buprenorphine planned | active | confirmed | F11.20 | S — Synthetic modern coding; tolerance and withdrawal are not counted for a medicine taken under medical supervision. Person-first language; not a claim about his real diagnosis. |
| Chronic pain after major trauma ten months ago (crushed chest with rib fractures, collapsed lung, other fractures and burns): chest wall, left shoulder and low back pain, PEG 6.7 | active | confirmed | G89.21 | S — Synthetic modern diagnosis anchored to his documented injuries. |
| Difficulty hearing conversation, worse in noise, after years of flying in loud aircraft; cause under evaluation | resolved | confirmed | H91.93 | S — Synthetic presenting problem; resolved into a diagnosis when audiometry was done at five weeks. His documented deafness is from later years. |
| Bilateral high-frequency sensorineural hearing loss with a notch at 4000 Hz, consistent with noise exposure from flying; hearing aids fitted | active | confirmed | H90.3 | S — Synthetic modern diagnosis made at five weeks; not a claim about his real hearing in 1947. |
| Weight loss of about 8 kg since the crash (BMI 19.7), from eating little outside food he has prepared or inspected himself because of contamination fears | active | confirmed | R63.4 | S — Synthetic nutrition problem linked to the contamination fears; not a claim about his real weight in 1947. |
| Acute bronchitis, likely viral, for five days; no pneumonia on examination; resolved within three weeks without antibiotics | resolved | confirmed | J20.9 | S — Synthetic acute illness; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1947-05-04 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1947-05-04 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 1947-05-04 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 91 | fL | 80-100 fL | Normal | S |
| 1947-05-04 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1947-05-04 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1947-05-04 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1947-05-04 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1947-05-04 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1942)/1.73 sq M | 104 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1947-05-04 | Glucose [Mass/volume] in Serum or Plasma | 84 | mg/dL | 70-99 mg/dL | Normal | S |
| 1947-05-04 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 10-40 U/L | Normal | S |
| 1947-05-04 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 7-56 U/L | Normal | S |
| 1947-05-04 | Albumin [Mass/volume] in Serum or Plasma | 3.7 | g/dL | 3.5-5 g/dL | Normal | S |
| 1947-05-04 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1947-05-04 | Albumin/Creatinine [Mass Ratio] in Urine | 8 | mg/g{creat} | <=29 mg/g{creat} | Normal | S |
| 1947-05-04 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S | ||
| 1947-05-04 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 12 | {score} | S | ||
| 1947-05-04 | Total score [DAST-10] | 5 | {score} | S | ||
| 1947-05-04 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 1947-05-04 | Mean score [PEG] | 6.7 | {score} | S | ||
| 1947-05-11 | PTSD PCL-5 score [PCL-5] | 18 | {score} | S | ||
| 1947-06-08 | Hearing threshold Ear - right --500 Hz | 20 | dB | 25 dB HL or better is normal hearing | Normal | S |
| 1947-06-08 | Hearing threshold Ear - left --500 Hz | 20 | dB | 25 dB HL or better is normal hearing | Normal | S |
| 1947-06-08 | Hearing threshold Ear - right --1000 Hz | 25 | dB | 25 dB HL or better is normal hearing | Normal | S |
| 1947-06-08 | Hearing threshold Ear - left --1000 Hz | 30 | dB | 25 dB HL or better is normal hearing | High | S |
| 1947-06-08 | Hearing threshold Ear - right --1921 Hz | 35 | dB | 25 dB HL or better is normal hearing | High | S |
| 1947-06-08 | Hearing threshold Ear - left --1921 Hz | 40 | dB | 25 dB HL or better is normal hearing | High | S |
| 1947-06-08 | Hearing threshold Ear - right --4000 Hz | 60 | dB | 25 dB HL or better is normal hearing | High | S |
| 1947-06-08 | Hearing threshold Ear - left --4000 Hz | 65 | dB | 25 dB HL or better is normal hearing | High | S |
| 1947-06-08 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 1947-06-08 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 10 | {score} | S | ||
| 1947-06-08 | Mean score [PEG] | 5.7 | {score} | S | ||
| 1947-07-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 1947-07-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S | ||
| 1947-07-13 | Mean score [PEG] | 4.7 | {score} | S | ||
| 1947-10-05 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1947-10-05 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1947-10-05 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1947-10-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1942)/1.73 sq M | 102 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1947-10-05 | Glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
| 1947-10-05 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 10-40 U/L | Normal | S |
| 1947-10-05 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 27 | U/L | 7-56 U/L | Normal | S |
| 1947-10-05 | Albumin [Mass/volume] in Serum or Plasma | 4.2 | g/dL | 3.5-5 g/dL | Normal | S |
| 1947-10-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1947-10-05 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | {score} | S | ||
| 1947-10-05 | Mean score [PEG] | 4 | {score} | S | ||
| 1947-09-14 | Cholesterol [Mass/volume] in Serum or Plasma | 182 | mg/dL | <=199 mg/dL | Normal | S |
| 1947-09-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 1947-09-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 | mg/dL | <=129 mg/dL | Normal | S |
| 1947-09-14 | Triglyceride [Mass/volume] in Serum or Plasma | 90 | mg/dL | <=149 mg/dL | Normal | S |
| 1947-09-14 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1947-05-04 | Body height | 191 | cm | S |
| 1947-05-04 | Body weight | 72 | kg | S |
| 1947-05-04 | Body mass index (BMI) [Ratio] | 19.7 | kg/m2 | S |
| 1947-05-04 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1947-05-04 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1947-05-04 | Heart rate | 92 | /min | S |
| 1947-05-04 | Respiratory rate | 16 | /min | S |
| 1947-05-04 | Body temperature | 36.7 | Cel | S |
| 1947-05-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1947-05-11 | Body height | 191 | cm | S |
| 1947-05-11 | Body weight | 72.3 | kg | S |
| 1947-05-11 | Body mass index (BMI) [Ratio] | 19.8 | kg/m2 | S |
| 1947-05-11 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1947-05-11 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1947-05-11 | Heart rate | 88 | /min | S |
| 1947-05-11 | Respiratory rate | 16 | /min | S |
| 1947-05-11 | Body temperature | 36.8 | Cel | S |
| 1947-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1947-06-08 | Body height | 191 | cm | S |
| 1947-06-08 | Body weight | 73.4 | kg | S |
| 1947-06-08 | Body mass index (BMI) [Ratio] | 20.1 | kg/m2 | S |
| 1947-06-08 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1947-06-08 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1947-06-08 | Heart rate | 78 | /min | S |
| 1947-06-08 | Respiratory rate | 14 | /min | S |
| 1947-06-08 | Body temperature | 36.6 | Cel | S |
| 1947-06-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1947-07-13 | Body height | 191 | cm | S |
| 1947-07-13 | Body weight | 74.6 | kg | S |
| 1947-07-13 | Body mass index (BMI) [Ratio] | 20.4 | kg/m2 | S |
| 1947-07-13 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1947-07-13 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1947-07-13 | Heart rate | 74 | /min | S |
| 1947-07-13 | Respiratory rate | 14 | /min | S |
| 1947-07-13 | Body temperature | 36.7 | Cel | S |
| 1947-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1947-10-05 | Body height | 191 | cm | S |
| 1947-10-05 | Body weight | 76.2 | kg | S |
| 1947-10-05 | Body mass index (BMI) [Ratio] | 20.9 | kg/m2 | S |
| 1947-10-05 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1947-10-05 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1947-10-05 | Heart rate | 72 | /min | S |
| 1947-10-05 | Respiratory rate | 14 | /min | S |
| 1947-10-05 | Body temperature | 36.6 | Cel | S |
| 1947-10-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1947-09-14 | Body height | 191 | cm | S |
| 1947-09-14 | Body weight | 75.6 | kg | S |
| 1947-09-14 | Body mass index (BMI) [Ratio] | 20.7 | kg/m2 | S |
| 1947-09-14 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1947-09-14 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1947-09-14 | Heart rate | 70 | /min | S |
| 1947-09-14 | Respiratory rate | 14 | /min | S |
| 1947-09-14 | Body temperature | 36.6 | Cel | S |
| 1947-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1947-06-22 | Body height | 191 | cm | S |
| 1947-06-22 | Body weight | 73.6 | kg | S |
| 1947-06-22 | Body mass index (BMI) [Ratio] | 20.2 | kg/m2 | S |
| 1947-06-22 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1947-06-22 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1947-06-22 | Heart rate | 84 | /min | S |
| 1947-06-22 | Respiratory rate | 18 | /min | S |
| 1947-06-22 | Body temperature | 37.4 | Cel | S |
| 1947-06-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1947-05-04 | Establishing primary care ten months after a plane crash: contamination fears with washing and avoidance, chronic pain on long-term codeine, an opioid review, hearing, weight, kidney health and safety | finished | S |
| 1947-05-11 | One-week review, seen the same day by psychiatry: the diagnosis of OCD, an SSRI, exposure and response prevention, and starting buprenorphine | finished | S |
| 1947-06-08 | Five-week review: OCD treatment, buprenorphine, pain, the audiogram and weight | finished | S |
| 1947-07-13 | Ten-week review: sertraline to an OCD dose, exposure therapy and his staff's part in it, hearing aids and pain | finished | S |
| 1947-10-05 | Twenty-two-week review: response of OCD, buprenorphine maintenance, pain, weight and laboratory checks | finished | S |
| 1947-09-14 | Periodic adult preventive visit | finished | S |
| 1947-06-22 | Same-day sick visit for a cough | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Psychiatry consultation to confirm the diagnosis, advise on an SSRI at OCD doses with buprenorphine, plan exposure and response prevention, and advise on how his staff can stop carrying out rituals for him | completed | GL-APA-OCD-2007, GL-APA-OCD-WATCH-2013, GL-NICE-CG31 | S |
| Opioid review under the CDC 1943 guideline: benefits and harms reviewed with him, a prescription drug monitoring program check before every controlled-substance prescription, urine drug testing with consent and explained as part of care, one prescriber and one pharmacy, a nonjudgmental DSM-5-TR assessment for opioid use disorder, and no abrupt stop of codeine | completed | GL-CDC-OPIOID-2022, GL-CDC-PDMP | S |
| Buprenorphine with naloxone for opioid use disorder and pain: induction in the clinic at one week after about 20 hours without codeine, then 8 mg twice daily, dispensed weekly at first; naloxone nasal spray at home; no benzodiazepines; leftover codeine to a pharmacy take-back | completed | GL-CDC-OPIOID-2022, GL-ASAM-OUD-2020 | S |
| Pain after major trauma: scheduled acetaminophen up to 3,000 mg a day, physical therapy for the chest wall, left shoulder and low back, graded activity, sleep, and pain coping skills woven into his therapy; no NSAID long term | completed | GL-CDC-OPIOID-2022 | S |
| OCD treatment: exposure and response prevention with a psychologist, weekly 90-minute sessions with home practice, then twice weekly; sertraline from 50 mg, raised every four to six weeks as tolerated toward 200 mg; response judged by the Y-BOCS at each visit; augmentation with a low-dose antipsychotic (aripiprazole or risperidone) or a switch to clomipramine considered only if the response is poor after 8 to 12 weeks at the highest tolerated dose | completed | GL-APA-OCD-2007, GL-APA-OCD-WATCH-2013, GL-NICE-CG31 | S |
| Accommodation by staff: with his written consent, his assistant joins two therapy sessions; staff stop carrying out rituals for him in planned steps that follow his exposure hierarchy, offer support instead of reassurance, and are not asked to report on him | completed | GL-APA-OCD-2007, GL-NICE-CG31 | S |
| Safety: a structured safety assessment, a written safety plan, the 988 Suicide & Crisis Lifeline in his phone, means safety for opioids, and safety review at every visit | completed | GL-SUICIDE-2024, GL-CMID-2026 | S |
| Hearing: audiometry, then hearing aids and a remote microphone if hearing loss is confirmed; hearing protection when flying and in the factory | completed | GL-NICE-NG98 | S |
| Nutrition and weight: a dietitian visit, three meals a day built into his exposure plan (food made by his cook, then food from a restaurant), weight at each visit, albumin at baseline and follow-up; no supplements needed | completed | GL-APA-OCD-2007 | S |
| Kidney health: creatinine, eGFR and urine albumin at baseline and a metabolic panel at follow-up while on scheduled acetaminophen and any new medicine; acetaminophen kept at or below 3,000 mg a day; no long-term NSAID | completed | GL-CDC-OPIOID-2022 | S |
| Privacy: care documented in the clinic record only; letters about his health go only to people he names | completed | GL-APA-OCD-2007 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Y-BOCS down by at least 35 percent (response) within six months | 1947-10-05 | completed | Y-BOCS 28 at intake, 14 at twenty-two weeks (a 50 percent fall); washing and checking about one hour a day | S |
| Stop codeine and stay on buprenorphine with no use of other opioids | 1947-10-05 | completed | Codeine stopped at one week; all urine tests positive for buprenorphine and negative for other opioids | S |
| Pain that lets him work and sleep: PEG at or below 4 | 1947-10-05 | active | PEG 6.7 at intake to 4.0 at twenty-two weeks | S |
| Regain weight to at least 76 kg with regular meals | 1947-10-05 | completed | 72.0 kg at intake to 76.2 kg; three meals a day, including food prepared by his cook | S |
| Follow conversation in meetings with hearing aids | 1947-10-05 | completed | Hearing aids fitted at ten weeks and worn every day | S |
| Staff stop carrying out rituals for him, step by step, by his own plan | 1947-10-05 | active | Tissue-wrapping and the hand-washing rule for staff stopped; food preparation rules relaxed; visitors no longer screened for illness | S |
Structured synthetic safety assessment on 1947-05-04: current ideation absent, intent absent, plan absent. Outpatient care with weekly visits at first. Risk factors reviewed without detail: a breakdown in earlier years, opioid use disorder, chronic pain, severe OCD, isolation and anxiety. No current thoughts of suicide. Opioids are dangerous in overdose, so means safety is part of the plan: naloxone nasal spray at home with his staff taught to use it, unused codeine tablets taken to a pharmacy take-back, and buprenorphine dispensed one week at a time at first. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit [S]